Company intelligence / Profile preview

Protenium Clinical Research

Hurst, Texas, United States

Ownership: Private
Development stage: Other

Overview

Protenium Clinical Research is an independent clinical research site in Hurst, Texas that conducts Phase I–IV FDA‑regulated pharmaceutical clinical trials across a broad range of therapeutic areas; in January 2019 it was acquired by Elligo Health Research and now operates as part of Elligo’s Research Ready network.[1][3][4]

Industry: Contract Research Organization

Partnerships

Elligo Health Research

Beyond the preview

Go deeper on Protenium Clinical Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protenium Clinical Research.

Explore the full profile